Skip to main content

Featured

Benefit Payments Before Christmas: What Lands When, and How to Plan Around It

  Canadian Money Brief Benefit Payments Before Christmas: What Lands When, and How to Plan Around It Sunday, November 15, 2026 If a government payment is part of your monthly budget, the next five weeks have an unusual rhythm. Two payments arrive this week, one more lands the day before Black Friday, and December's cheques come early. Knowing the order is the easiest way to avoid a short month. This Week: Two Payments, Back to Back The Canada Disability Benefit is paid Thursday, Nov 19, and the Canada Child Benefit follows on Friday, Nov 20. The disability benefit pays up to $204.20 a month, and Ottawa pays it on the third Thursday of every month. The CCB pays up to $679.75 a month for each child under 6 and $573.58 for each child aged 6 to 17. Those are maximums, and they go to families with adjusted family net income under $38,237. The amount shrinks as income rises above that level. Black Friday Falls the Day After CPP and OAS CPP, OAS and GIS all pay on Thursday, Nov 26. Bla...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments